CHMP backing for CORT's Lifyorli combo in platinum-resistant ovarian cancer signals regulatory catalyst.
Why it matters
CHMP backing for CORT's Lifyorli combo in platinum-resistant ovarian cancer signals regulatory catalyst. — impact context not separately stored; see What changed.